⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Pimecrolimus cream 1%

پیمکرولیموس کرم ۱٪

⚠ Unverified

🧴 DermatologicalsTopical calcineurin inhibitor

🤰 Pregnancy:Use with caution 🤱 Breastfeeding:Dangerous / avoid 👶 Children:Use with caution 👴 Older adults:Use with caution 🇮🇷 Registered in Iran ⛔ 1 contraindications 🇺🇸 FDA authorized generic NDA021302 ATC D11AH02

Market / country: 🇺🇸 USA

Elidel (US)

🧮 Dose calculator

Disease / regimen

Atopic dermatitis (eczema) · Regimen source: FDA Pimecrolimus · 2 FDA Pimecrolimus · 1

⛔ Thin layer twice daily until signs resolve; re-examine if symptoms persist beyond 6 weeks. Avoid continuous long-term use; affected areas only. FDA Pimecrolimus · 2 FDA Pimecrolimus · 1

🛡️ Safety & information

Contraindications

⛔ Hypersensitivity to pimecrolimus. FDA Pimecrolimus · 4

Warnings

• Boxed warning: long-term safety not established; rare malignancy (skin, lymphoma). Not for immunocompromised patients or under 2 years. FDA Pimecrolimus · Boxed Warning

Formulations

Pimecrolimus 1% cream — cream 🇺🇸 USA FDA Pimecrolimus · 3

👥 Special populations

🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Pimecrolimus · 8.1
“Pregnancy Category C There are no adequate and well-controlled studies with Pimecrolimus Cream, 1% in pregnant women.”
🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Pimecrolimus · 8.3
“Because of the potential for serious adverse reactions in nursing infants from pimecrolimus, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
👶 ChildrenUse with caution
Label: only ≥2 years and second line; not indicated under 2 years. FDA Pimecrolimus · 8.4
“Pimecrolimus Cream, 1% is not indicated for use in children less than 2 years of age”
👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Pimecrolimus · 8.5
“Nine (9) subjects ≥65 years old received Pimecrolimus Cream, 1% in Phase 3 trials.”
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)NDA021302
DailyMed (FDA label)FDA Pimecrolimus
MedlinePlus (NIH)❌ None
WHO ATC/DDDD11AH02
Darooyab (Iran)Pimecrolimus

🇮🇷 Registered in Iran Darooyab · G-2308/Pimecrolimus

Dosage forms with Iranian generic codes, per Darooyab.

07760 · PIMECROLIMUS 1% 15G CREAM · کرم پیمکرولیموس ۱ درصد ۱۵ گرم
05421 · PIMECROLIMUS 1% 30G CREAM · کرم پیمکرولیموس ۱ درصد ۳۰ گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Pimecrolimus · 3 FDA Pimecrolimus · 2 FDA Pimecrolimus · 1 FDA Pimecrolimus · 4 FDA Pimecrolimus · Boxed Warning FDA Pimecrolimus · 8.1 FDA Pimecrolimus · 8.3 FDA Pimecrolimus · 8.4 FDA Pimecrolimus · 8.5 FDA Pimecrolimus · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-2308/Pimecrolimus
Clinical review⚠ Unverified

🔗 Similar drugs

Same class

Tacrolimus ointment